Literature DB >> 20624651

Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibility.

Xiaoguang Sun1, Shwu-Fan Ma, Michael S Wade, Carlos Flores, Maria Pino-Yanes, Jaideep Moitra, Carole Ober, Rick Kittles, Aliya N Husain, Jean G Ford, Joe G N Garcia.   

Abstract

BACKGROUND: The genetic mechanisms underlying asthma remain unclear. Increased permeability of the microvasculature is a feature of asthma, and the sphingosine-1-phosphate receptor (S1PR1) is an essential participant regulating lung vascular integrity and responses to lung inflammation.
OBJECTIVE: We explored the contribution of polymorphisms in the S1PR1 gene to asthma susceptibility.
METHODS: A combination of gene resequencing for single nucleotide polymorphism (SNP) discovery, case-control association, functional evaluation of associated SNPs, and protein immunochemistry studies was used.
RESULTS: Immunohistochemistry studies demonstrated significantly decreased S1PR1 protein expression in pulmonary vessels in lungs of asthmatic patients compared with those of nonasthmatic subjects (P < .05). Direct DNA sequencing of 27 multiethnic samples identified 39 S1PR1 variants (18 novel SNPs). Association studies were performed based on genotyping results from cosmopolitan tagging SNPs in 3 case-control cohorts from Chicago and New York totaling 1,061 subjects (502 cases and 559 control subjects). The promoter SNP rs2038366 (-1557G/T) was found to be associated with asthma (P = .03) in European Americans. In African Americans an association was found for both asthma and severe asthma for intronic SNP rs3753194 (c.-164+170A/G; P = .006 and P = .040, respectively) and for promoter SNP rs59317557 (-532C/G) with severe asthma (P = .028). Consistent with predicted in silico functionality, alleles of the promoter SNPs rs2038366 (-1557G/T) and rs59317557 (-532C/G) influenced the activity of a luciferase S1PR1 reporter vector in transfected endothelial cells exposed to growth factors (epidermal growth factor, platelet-derived growth factor, and vascular endothelial growth factor) known to be increased in asthmatic airways.
CONCLUSION: These data provide strong support for a role for S1PR1 gene variants in asthma susceptibility and severity. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624651      PMCID: PMC3495167          DOI: 10.1016/j.jaci.2010.04.036

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  65 in total

1.  Association mapping in structured populations.

Authors:  J K Pritchard; M Stephens; N A Rosenberg; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-05-26       Impact factor: 11.025

2.  Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations.

Authors:  C Ober; S A Leavitt; A Tsalenko; T D Howard; D M Hoki; R Daniel; D L Newman; X Wu; R Parry; L A Lester; J Solway; M Blumenthal; R A King; J Xu; D A Meyers; E R Bleecker; N J Cox
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

3.  Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis.

Authors:  D English; Z Welch; A T Kovala; K Harvey; O V Volpert; D N Brindley; J G Garcia
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

4.  Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma.

Authors:  A J Ammit; A T Hastie; L C Edsall; R K Hoffman; Y Amrani; V P Krymskaya; S A Kane; S P Peters; R B Penn; S Spiegel; R A Panettieri
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

5.  Platelet-derived growth factor is involved in the augmentation of airway responsiveness through remodeling of airways in diesel exhaust particulate-treated mice.

Authors:  N Yamashita; K Sekine; T Miyasaka; R Kawashima; Y Nakajima; J Nakano; T Yamamoto; T Horiuchi; K Hirai; K Ohta
Journal:  J Allergy Clin Immunol       Date:  2001-01       Impact factor: 10.793

6.  Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.

Authors:  D English; A T Kovala; Z Welch; K A Harvey; R A Siddiqui; D N Brindley; J G Garcia
Journal:  J Hematother Stem Cell Res       Date:  1999-12

7.  Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.

Authors:  J P Hobson; H M Rosenfeldt; L S Barak; A Olivera; S Poulton; M G Caron; S Milstien; S Spiegel
Journal:  Science       Date:  2001-03-02       Impact factor: 47.728

Review 8.  The role of sphingosine kinase in the signaling initiated at the high-affinity receptor for IgE (FcepsilonRI) in mast cells.

Authors:  T Baumruker; E E Prieschl
Journal:  Int Arch Allergy Immunol       Date:  2000-06       Impact factor: 2.749

9.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

10.  Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung.

Authors:  Saad Sammani; Liliana Moreno-Vinasco; Tamara Mirzapoiazova; Patrick A Singleton; Eddie T Chiang; Carrie L Evenoski; Ting Wang; Biji Mathew; Aliya Husain; Jaideep Moitra; Xiaoguang Sun; Luis Nunez; Jeffrey R Jacobson; Steven M Dudek; Viswanathan Natarajan; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2009-09-11       Impact factor: 6.914

View more
  26 in total

1.  Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury.

Authors:  Xiaoguang Sun; Patrick A Singleton; Eleftheria Letsiou; Jing Zhao; Patrick Belvitch; Saad Sammani; Eddie T Chiang; Liliana Moreno-Vinasco; Michael S Wade; Tong Zhou; Bin Liu; Ioannis Parastatidis; Leonor Thomson; Harry Ischiropoulos; Viswanathan Natarajan; Jeffrey R Jacobson; Roberto F Machado; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2012-07-05       Impact factor: 6.914

2.  Genomic investigations into acute inflammatory lung injury.

Authors:  Joe G N Garcia
Journal:  Proc Am Thorac Soc       Date:  2011-05

3.  Oroscomucoid like protein 3 (ORMDL3) transgenic mice have reduced levels of sphingolipids including sphingosine-1-phosphate and ceramide.

Authors:  Marina Miller; Peter Rosenthal; Andrew Beppu; Ruth Gordillo; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2016-11-05       Impact factor: 10.793

4.  Cutting Edge: Targeting Epithelial ORMDL3 Increases, Rather than Reduces, Airway Responsiveness and Is Associated with Increased Sphingosine-1-Phosphate.

Authors:  Marina Miller; Arvin B Tam; James L Mueller; Peter Rosenthal; Andrew Beppu; Ruth Gordillo; Matthew D McGeough; Christine Vuong; Taylor A Doherty; Hal M Hoffman; Maho Niwa; David H Broide
Journal:  J Immunol       Date:  2017-03-08       Impact factor: 5.422

5.  Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.

Authors:  Hideru Obinata; Sarah Gutkind; Jeremiah Stitham; Toshiaki Okuno; Takehiko Yokomizo; John Hwa; Timothy Hla
Journal:  J Lipid Res       Date:  2014-10-07       Impact factor: 5.922

Review 6.  Advances in pediatric asthma in 2010: addressing the major issues.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

Review 7.  The outs and the ins of sphingosine-1-phosphate in immunity.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Immunol       Date:  2011-05-06       Impact factor: 53.106

8.  Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome.

Authors:  Xiaoguang Sun; Shwu-Fan Ma; Michael S Wade; Marialbert Acosta-Herrera; Jesús Villar; Maria Pino-Yanes; Tong Zhou; Bin Liu; Patrick Belvitch; Jaideep Moitra; Yoo-Jeong Han; Roberto Machado; Imre Noth; Viswanathan Natarajan; Steven M Dudek; Jeffrey R Jacobson; Carlos Flores; Joe G N Garcia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-02       Impact factor: 5.464

9.  Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α.

Authors:  Xiaoguang Sun; Belinda L Sun; Aleksandra Babicheva; Rebecca Vanderpool; Radu C Oita; Nancy Casanova; Haiyang Tang; Akash Gupta; Heather Lynn; Geetanjali Gupta; Franz Rischard; Saad Sammani; Carrie L Kempf; Liliana Moreno-Vinasco; Mohamed Ahmed; Sara M Camp; Jian Wang; Ankit A Desai; Jason X-J Yuan; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2020-07       Impact factor: 6.914

10.  The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants.

Authors:  Xiaoguang Sun; Venkateswaran Ramamoorthi Elangovan; Brandon Mapes; Sara M Camp; Saad Sammani; Laleh Saadat; Ermelinda Ceco; Shwu-Fan Ma; Carlos Flores; Matthew S MacDougall; Hector Quijada; Bin Liu; Carrie L Kempf; Ting Wang; Eddie T Chiang; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.